12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Other News

Indel Therapeutics, Simon Fraser University, University of British Columbia infectious news

The universities partnered with Indel to identify targets and compounds to treat antibiotic-resistant nosocomial pathogens, or hospital-acquired infections. In June, the...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >